-

May 2nd, 2012

Podcast 154: Treating heart failure’s hypercoagulable state — warfarin or aspirin?

(9 votes, average: 3.11 out of 5)

Heart failure brings problems associated with hypercoagulation, such as stroke and sudden death.

An international study followed some 2300 patients with heart failure (ejection fractions of 35% or less) and in stable sinus rhythm for a mean of 3.5 years, randomizing them to treatment with either warfarin or aspirin.

The two treatment groups showed about the same risks for stroke and overall mortality, but warfarin was associated with more major bleeding episodes.

Our guest is the first author on the report, released online by the New England Journal of Medicine.

Links:

NEJM article

Leave a Reply

Note: This is a moderated forum. By clicking on the "Submit Comment" button below, you agree to abide by the NEJM Journal Watch Terms of Use.

Our physician bloggers cannot respond to requests for personal medical advice, and recommend patients discuss health issues with their individual physicians.

Clinical Conversations

About the Podcast

To subscribe: Subscribe on iTunes

To have your comment included in a future podcast, call 617-440-4374. Please leave your name, number, and the podcast ID number.